Investing.com - AbbVie (NYSE:ABBV) reported on Friday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
AbbVie announced earnings per share of $2.95 on revenue of $12.94B. Analysts polled by Investing.com anticipated EPS of $2.81 on revenue of $12.76B.
AbbVie shares are up 3% from the beginning of the year and are trading at $112.30 , down-from-52-week-high.They are under-performing the S&P 500 which is up 12.12% from the start of the year.
AbbVie shares gained 1.27% in pre-market trade following the report.
AbbVie follows other major Healthcare sector earnings this month
AbbVie's report follows an earnings beat by J&J on Tuesday, April 20, 2021, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B.
Abbott Labs had beat expectations on Tuesday, April 20, 2021 with first quarter EPS of $1.32 on revenue of $10.46B, compared to forecast for EPS of $1.27 on revenue of $10.69B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar